Who
Lynnette C. Fallon
Director
Company insider
Files Form 4 as: Director, ClearPoint Neuro; Executive VP, Hr/Legal, Axcelis Technologies.
In numbers
- Trades disclosed
- 198
- Buys
- 5
- Sells
- 35
- Bought
- $39K
- Sold
- $13.1M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 30 Dec 2005
- Last trade
- 21 May 2026
- Last filed
- 26 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 26 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,820 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,820 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Sold | $57K5,091 at $11.14 | filing |
| 20 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Sold | $57K5,091 at $11.14 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 19 May 2026filed 21 May 2026 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —12,417 | filing |
| 3 Jun 2025filed 5 Jun 2025 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Sold | $113K9,000 at $12.53 | filing |
| 3 Jun 2025filed 5 Jun 2025 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Sold | $15K1,200 at $12.88 | filing |
| 22 May 2025filed 23 May 2025 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —12,417 at $0.00 | filing |
| 16 May 2025filed 19 May 2025 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code M | —21,093 | filing |
| 16 May 2025filed 19 May 2025 | CLPT ClearPoint NeuroMedical Devices | SEC FORM 4 Code M | —21,093 | filing |
| 3 Jan 2025filed 7 Jan 2025 | ACLS Axcelis TechnologiesSemiconductor Equipment | SEC FORM 4 Code F | $222K3,083 at $71.96 | filing |
| 5 Jun 2024filed 5 Jun 2024 | ACLS Axcelis TechnologiesSemiconductor Equipment | SEC FORM 4 Code F | $30K272 at $111.29 | filing |
| 17 May 2024filed 20 May 2024 | ACLS Axcelis TechnologiesSemiconductor Equipment | SEC FORM 4 Code F | $99K872 at $113.23 | filing |
| 16 May 2024filed 17 May 2024 | CLPT ClearPoint Neurooption or derivative · Medical Devices | SEC FORM 4 Code A | —21,093 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | ACLS Axcelis TechnologiesSemiconductor Equipment | SEC FORM 4 Code F | $71K628 at $113.57 | filing |
| 15 May 2024filed 17 May 2024 | ACLS Axcelis TechnologiesSemiconductor Equipment | SEC FORM 4 Code A | —3,200 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | ACLS Axcelis TechnologiesSemiconductor Equipment | SEC FORM 4 Code F | $115K1,017 at $112.94 | filing |
News
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, ...CLPT · pr-inside.com · 14 Oct 2026
0 headlines in the last 90 days name Lynnette C. Fallon; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.